References
- Streufert S, Satish U, Barach P. Improving medical care: the use of simulation technology. Simulation & Gaming 2001; 32: 164–174.
- Kuntz K, Weinstein M. Modelling in economic evaluation. In: Drummond M, McGuire A, Editors. Economic Evaluation in Health Care: Merging Theory with Practice. Oxford, UK: Oxford University Press, 2002: 141–171.
- Ramsey SD, McIntosh M, Etzioni R et al. Simulation modeling of outcomes and cost effectiveness. Hematology/Oncology Clinics of North America 2000; 14: 925–938.
- Weinstein MC, Toy EL, Sandberg EA et al. Modeling for health care and other policy decisions: uses, roles, and validity. Value in Health 2001; 4: 348–361.
- Coyle D, Lee KM, O’Brien BJ. The role of models within economic analysis: focus on type 2 diabetes mellitus. PharmacoEconomics 2002; 20(Suppl 1): 11–19.
- Bergemann R, Suissa S, Morris A et al. A simulation model for diabetes type 1 and 2: model description and internal validation process with UKPDS, DCCT and WESDR. Diabetologia 2001; 44(Suppl 1): Abstract 114.
- Hauner H, Maxion-Bergmann S, Muller E et al. [Disease management program (DMP) diabetes mellitus: simulation of therapeutic results of different guidelines. A new diabetes mellitus model (DMM).] Deutsche Medizinische Wochenschrift (1946) 2003; 128: 1167–72 [in German].
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837– 853.
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998; 317: 703–713.
- The effect of intensive treatment of diabetes on the development and progression of long- term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. New England Journal of Medicine 1993; 329: 977– 986.
- Moss SE, Klein R, Klein BE. The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 1999; 22: 951–959.
- Bergemann R, Hauner H, Morris A et al. Prediction of acute and chronic complications by a new computer simulation model for type 1 and type 2 diabetes: the Diabetes Mellitus Model (DMM). Journal of Medical Economics 2006; 9: 83–99.
- Sculpher M, Fenwick E, Claxton K. Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application. PharmacoEconomics 2000; 17: 461–477.
- Ahrens J, Dieter U. Extensions of Forsythe’s method for random sampling from the Normal distribution. Math Comput 1973; 27: 927–937.
- James F. RANFLUX: a Fortran implementation of the high-quality pseudorandom number generator. Computer Physics Communications 1994; 79: 111–114.
- Moss SE, Klein R, Klein BE. The 14-year incidence of visual loss in a diabetic population. Ophthalmology 1998; 105: 998–1003.
- Klein R, Klein BE, Moss SE et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998; 105: 1801–1815.
- Klein R, Klein BE, Moss SE et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 1995; 102: 7–16. Klein R, Klein BE, Moss SE et al. The 10-year incidence of renal insufficiency in people with type 1 diabetes. Diabetes Care 1999; 22: 743–751.
- Moss SE, Klein R, Klein BE. The prevalence and incidence of lower extremity amputation in a diabetic population. Archives of Internal Medicine 1992; 152: 610–616.
- Stratton I, Adler A, Neil A et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405–412.
- Adler AI, Stratton IM, Neil HA et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321: 412–419.
- Bojestig M, Arnqvist HJ, Hermansson G et al. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. New England Journal of Medicine 1994; 330: 15–18.